PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR PEPTIDE DRUG DELIVERY SYSTEM-DESIGN

被引：9
|
作者：
BREIMER, DD
机构：
[1] Center for Bio-Pharmaceutical Sciences, Leiden University, Leiden
来源：
JOURNAL OF CONTROLLED RELEASE | 1992年 / 21卷 / 1-3期
关键词：
NEW DRUG DELIVERY; PHARMACOKINETICS; PHARMACODYNAMICS; PEPTIDE AND PROTEIN DRUGS;
D O I：
10.1016/0168-3659(92)90003-A
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：5 / 10
页数：6
相关论文
共 50 条
  • [31] Pharmacokinetic/Pharmacodynamic Modeling To Predict the Antiplatelet Effect of the Ticagrelor-Loaded Self-Microemulsifying Drug Delivery System in Rats
    Na, Young-Guk
    Byeon, Jin-Ju
    Kim, Min-Ki
    Han, Min-Gu
    Cho, Cheong-Weon
    Baek, Jong-Suep
    Lee, Hong-Ki
    Shin, Young G.
    MOLECULAR PHARMACEUTICS, 2020, 17 (04) : 1079 - 1089
  • [32] Pharmacokinetic and pharmacodynamic modelling in paediatric drug development with a focus on physiology-based pharmacokinetic simulations
    Laeer, Stephanie
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2019, 141 : 66 - 73
  • [33] Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin
    Yan, Jing-He
    Meyers, Dan
    Lee, Zachary
    Danis, Kate
    Neelakantham, Srikanth
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07) : 800 - 808
  • [34] Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments
    Hooker, A
    Vicini, P
    AAPS JOURNAL, 2005, 7 (04) : E759 - E785
  • [35] Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
    Smit, Cornelis
    De Hoogd, Sjoerd
    Bruggemann, Roger J. M.
    Knibbe, Catherijne A. J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (03) : 275 - 285
  • [36] Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments
    Andrew Hooker
    Paolo Vicini
    The AAPS Journal, 7
  • [37] Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis
    Kloprogge, Frank
    Mwandumba, Henry C.
    Banda, Gertrude
    Kamdolozi, Mercy
    Shani, Doris
    Corbett, Elizabeth L.
    Kontogianni, Nadia
    Ward, Steve
    Khoo, Saye H.
    Davies, Geraint R.
    Sloan, Derek J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (07):
  • [38] Mechanism-based pharmacokinetic–pharmacodynamic modeling of antimicrobial drug effects
    David Czock
    Frieder Keller
    Journal of Pharmacokinetics and Pharmacodynamics, 2007, 34 : 727 - 751
  • [39] Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development
    Dingemanse, Jasper
    Krause, Andreas
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 109 : S53 - S58
  • [40] Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development
    Sarker, Debashis
    Pacey, Simon
    Workman, Paul
    BIOMARKERS IN MEDICINE, 2007, 1 (03) : 399 - 417
12345